Core Insights - Qualigen Therapeutics, Inc. announced significant leadership and governance changes to enhance its executive team and financial transparency, supporting its strategic growth phase [1] Executive Appointments - Jerry (Jiawei) Wang appointed as Co-Chief Executive Officer and Koti Meka as Chief Financial Officer effective October 2, 2025 [2] - Wang has a background as Global President and founding team member of Faraday Future, involved in raising over $3 billion and leading its IPO in 2021 [2] - Meka previously served as CFO of Faraday Future and has extensive experience at Ford Motor Company in finance roles [3] Board of Directors Expansion and Changes - Following a private placement on September 29, 2025, Qualigen's Board appointed three new members: Chad Chen, Kevin Chen, and Jay Sheng [4] - Jay Sheng has experience as Head of Operations & Finance Director at FF Global Partners LLC and previously served in a senior role at China Aviation Fuel [5] - Kevin Chen is Chief Economist and Chief Investment Officer at Horizon Financial, with board roles in multiple publicly listed companies [6] - Chad Chen is a partner at Yoka | Smith, LLP, with a focus on corporate litigation and business transactions [7] Resignations - Cody Price and Robert Lim resigned from the Board, and Campbell Becher stepped down as Director but remains President; all resignations were amicable [8][9] Auditor Transition - On October 3, 2025, Macias Gini & O'Connell LLP was engaged as the new independent auditor for the fiscal year ending December 31, 2025 [10] - WhitumSmith+Brown, PC resigned as Qualigen's auditor effective October 1, 2025, with no disagreements reported [11] Strategic Outlook - The leadership and governance changes are seen as a crucial step for Qualigen, positioning the company for long-term growth and shareholder value [12] - Qualigen focuses on developing innovative oncology and immunology therapeutics and is exploring crypto and web3 initiatives for global growth [12]

Core Insights - Univest Securities announced a strategic investment of $41 million in Qualigen Therapeutics, led by Faraday Future with approximately $30 million [1][2][3] - The investment allows Faraday Future to hold approximately 55% of Qualigen's pro forma common stock, with YT Jia, the Founder and Global Co-CEO of Faraday Future, holding approximately 7% [3] Investment Details - The total investment of $41 million includes $30 million from Faraday Future and an additional $4 million from YT Jia, along with contributions from other investors such as SIGN Foundation, Sequoia Capital, IDG, and Circle [2] - The strategic investment was first announced during Faraday Future's annual 919 Futurist Day on September 19, 2025, marking a significant milestone in the execution of FF's "Dual-Flywheel & Dual-Bridge" Eco-Strategy [3] Company Profiles - Qualigen Therapeutics is a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer, with investigational compounds targeting various cancers [6] - Faraday Future is a California-based company aiming to disrupt the automotive industry through a user-centric, technology-first approach, with its flagship model being the FF 91 [5]

Core Insights - Faraday Future has completed its strategic investment in Qualigen Therapeutics, focusing on Crypto and Web3-related businesses [1][3] Investment Details - The total investment amounts to approximately $41 million, with Faraday Future leading with about $30 million, and founder Jia Yueting personally investing around $4 million [3] - Other investors include Binance Labs, Sequoia Capital, IDG, and Circle, participating through the SIGN Foundation [3] - Following the investment, Faraday Future holds approximately 55% of QLGN shares, while Jia Yueting holds about 7% and has voluntarily locked his shares for two years [3] Strategic Initiatives - The investment marks a key milestone in Faraday Future's "Dual Flywheel & Dual Bridge" ecological strategy [3] - The company plans to integrate its EAI EV assets onto the blockchain, creating an ecosystem that combines "EAI Mobility + Web3 + Blockchain Technology + Crypto Asset Applications" [3] - Faraday Future has also announced a Crypto Flywheel business, which will be independently operated by its wholly-owned subsidiary, FFAI Crypto Treasury and Bridging Holdings Inc. [4]

Core Insights - Faraday Future Intelligent Electric Inc. has completed a strategic investment in Qualigen Therapeutics, focusing on Crypto and Web3 related businesses [1] Investment Details - The total investment amount is approximately $41 million, with Faraday Future leading with about $30 million [1] - Founder and Co-CEO Jia Yueting personally invested around $4 million, alongside other investors including Binance Labs, Sequoia Capital, IDG, and Circle supporting the blockchain technology company SIGN Foundation [1]

Core Insights - Qualigen Therapeutics, Inc. has successfully closed a $41 million private investment in public equity (PIPE) financing, led by Faraday Future Intelligent Electric Inc. and other prominent investors [1][2] - The financing will primarily support the establishment of a new crypto business venture, CXC10, as the company transitions into a Web3 and crypto-focused entity [2][3] Investment Details - Faraday Future has invested $30 million in Qualigen's common and preferred stock, equating to approximately 55% of pro forma beneficial ownership [2] - YT Jia, the Founder and Global Co-CEO of Faraday Future, has personally invested around $4 million, representing about 7% ownership, and has committed to a two-year voluntary lockup [2] Strategic Transformation - Qualigen is undergoing a strategic transformation to rebrand as CXC10, focusing on bridging Web2 and Web3, as well as integrating AI and crypto [3] - The company aims to develop three growth engines with six key products under the CXC10 brand, positioning itself as a leading U.S. public company in the crypto space [3][7] Leadership Changes - As part of the investment, Jerry Wang has joined Qualigen as Co-CEO, while YT Jia will serve as Chief Advisor [4] - Koti Meka, CFO of Faraday Future, has been appointed as CFO of Qualigen [4] Future Plans - The company plans to enhance its strategic focus, strengthen technical capabilities, and adopt an open ecosystem approach to achieve its goals [5]

Core Insights - Faraday Future Intelligent Electric Inc. is transitioning to a new strategic direction by investing in Qualigen Therapeutics, which is expected to rebrand as CXC10, focusing on crypto and Web3 business [1][2] Investment Details - The total investment in Qualigen Therapeutics amounts to approximately $41 million, with Faraday Future contributing around $30 million and an additional $4 million from YT Jia, the Founder and Global Co-CEO [2] - Other investors include SIGN Foundation, Sequoia Capital, IDG, and Circle [2] Ownership Structure - Following the investment, Faraday Future holds approximately 55% of Qualigen's pro forma common stock, while YT Jia holds about 7%, which he has committed to lock up for two years [3] Strategic Significance - This investment marks a critical milestone in Faraday Future's "Dual-Flywheel & Dual-Bridge" Eco-Strategy, linking electric automotive innovation with crypto and Web3 [3][4] - YT Jia emphasized that this ecosystem aims to create new value for both stockholders and token holders across Faraday Future and CXC10 [4] Company Overview - Faraday Future is a California-based company founded in 2014, focused on disrupting the automotive industry through a user-centric and technology-first approach [4] - The flagship model, FF 91, represents the company's vision for luxury and innovation, with plans to introduce mass production models targeting a broader market [4]

Core Insights - Qualigen Therapeutics (QLGN) shares experienced a significant surge of approximately 200% after securing a $41 million investment from Faraday Future (FFAI) and its founder YT Jia, indicating strong investor enthusiasm for the company's rebranding to CXC10 and its pivot into crypto-Web3 [1][3] - Despite the initial spike, QLGN shares have since retraced much of the gains but remain up nearly 190% from year-to-date lows [2] - The partnership with Faraday, which holds a 55% stake and Jia's additional 7% under a two-year lockup, adds credibility and potential for growth to the newly rebranded CXC10 [3] Financial and Strategic Overview - The pivot towards crypto and Web3 introduces speculative upside, particularly with early gains from the C10 treasury and the promise of AI-driven trading via BesTrade [4] - The transition represents a significant departure from the company's biotech origins, raising concerns about execution and long-term viability [4][5] - Qualigen Therapeutics has a history of operating losses, limited revenue, and a strained balance sheet, which could lead to dilution risks [5][6] Valuation and Market Position - Valuation remains challenging due to the lack of proven product-market fit in the crypto space, with only a 7% gain on its treasury being inconclusive [6] - Regulatory uncertainty, execution risk, and speculative elements contribute to the perception of QLGN stock as a high-risk investment [6]

Group 1: Super League Enterprise, Inc. - Super League Enterprise, Inc. announced a $10 million strategic equity investment from Evo Fund, leading to a sharp increase in its stock price [1] - Shares of Super League Enterprise rose 200% to $9.83 in pre-market trading following the announcement [1] Group 2: Other Notable Gainers - Professional Diversity Network, Inc. gained 88.8% to $5.40 in pre-market trading after a previous rise of around 4% [4] - STRATA Skin Sciences, Inc. rose 80% to $3.06 in pre-market trading after an 8% increase on Monday [4] - Jiuzi Holdings, Inc. jumped 50.9% to $1.69 in pre-market trading after a 5% gain on Monday [4] - New Era Energy & Digital, Inc. gained 47.2% to $0.8941 in pre-market trading after a surge of around 12% on Monday [4] - Better Home & Finance Holding Company increased by 30% to $64.95 in pre-market trading, following a 46% jump on Monday [4] - MicroCloud Hologram Inc. surged 29% to $7.17 in pre-market trading after announcing a breakthrough in quantum technology [4] - Cassava Sciences, Inc. rose 24.1% to $2.88 in pre-market trading after CEO Richard Barry purchased shares at an average price of $2.25 [4] - SES AI Corporation surged 10.3% to $2.04 in pre-market trading after a 17% increase on Monday [4] - Ballard Power Systems Inc. gained 8.3% to $3.12 in pre-market trading after a 5% rise on Monday [4] Group 3: Notable Decliners - Psyence Biomedical Ltd. dipped 19.6% to $3.65 in pre-market trading after a decline of around 5% on Monday [4] - Diginex Limited shares fell 17.7% to $14.60 in pre-market trading after a jump of over 30% on Monday [4] - Addentax Group Corp. declined 16.5% to $0.9021 in pre-market trading after gaining more than 30% on Monday [4] - Boxlight Corporation fell 15.5% to $4.03 in pre-market trading after a significant jump of 205% on Monday [4] - Reliance Global Group, Inc. dropped 15.5% to $0.9122 in pre-market trading after a 47% increase on Monday [4] - Qualigen Therapeutics, Inc. declined 14.1% to $4.75 in pre-market trading after a 95% jump on Monday [4] - Fly-E Group, Inc. fell 13.1% to $0.8773 in pre-market trading after announcing a securities purchase agreement [4] - Firefly Aerospace Inc. dropped 12.5% to $43.29 in pre-market trading after reporting a second-quarter loss [4] - Opendoor Technologies Inc. dipped 6.3% to $7.85 in pre-market trading after a 12% fall on Monday [4] - Symbotic Inc. fell 4.8% to $57.80 in pre-market trading after a gain of more than 6% on Monday [4]

Company Acquisitions - Pfizer Inc. has agreed to acquire Metsera, Inc. to enhance its portfolio in medicines targeting obesity and cardiometabolic diseases, introducing a range of oral and injectable therapy candidates [2] Stock Market Performance - U.S. stocks showed a mostly positive trend, with the Nasdaq Composite gaining over 50 points, while the Dow increased by 0.01% to 46,321.12, and the S&P 500 rose by 0.15% to 6,674.60 [1] - Information technology shares increased by 0.4%, while consumer staples stocks fell by 0.5% [1] Commodity Market - Oil prices decreased by 0.7% to $62.23, while gold prices increased by 1.3% to $3,752.30. Silver rose by 2.1% to $43.835, and copper fell by 0.4% to $4.6085 [5] Stock Movements - AgriFORCE Growing Systems Ltd. saw a significant increase of 157% to $6.20 following its announcement to rename and raise approximately $550 million [9] - Qualigen Therapeutics, Inc. surged by 141% to $6.86 after a $41 million investment from Faraday Future [9] - MBX Biosciences, Inc. rose by 134% to $23.43 after positive trial results for its product [9] - Chijet Motor Company, Inc. shares dropped by 38% to $0.1813 following the appointment of a new COO [9] - Cosan S.A. shares fell by 23% to $4.3850 after a downgrade from HSBC [9] - Quantum Computing Inc. experienced a decline of 14% to $19.97 after announcing a $500 million private placement [9]

Group 1 - Faraday Future (FFAI.US) shares declined over 8%, trading at $1.625 [1] - The company announced a $41 million investment in Qualigen Therapeutics (QLGN.US) to support its entry into the crypto and Web3 sectors [1] - Following the investment announcement, Qualigen Therapeutics' stock surged over 95%, reaching $5.55 [1] Group 2 - The investment will provide Faraday Future with significant equity in Qualigen and plans to appoint a management team to lead new business activities [1]